By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Personalized medicine software firm Proventys has raised nearly $3.3 million in an offering it hopes will bring in a total of $5.1 million, the firm said in a document filed with the US Securities and Exchange Commission.

The company did not say how the funds would be used.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.